Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

GTBP Financial Statements and Analysis

NASDAQ : GTBP

GT Biopharma, Inc.

$2.46
0.43+21.18%
At Close 4:00 PM
$2.43
-0.03-1.22%
After-Market 07:19 PM
62.97
B-ESG ScoreESG Rating

GTBP FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

GTBP Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue00000
gross profit00000
gross profit ratio00000
research and development expenses1.307M1.784M777.00K1.357M1.364M
general and administrative expenses02.122M000
selling and marketing expenses00000
selling general and administrative expenses2.297M2.122M2.314M1.811M1.758M
other expenses0027.00K00
operating expenses3.604M3.906M3.091M3.168M3.122M
cost and expenses3.604M3.906M3.091M3.168M3.122M
interest income96.00K105.00K142.00K180.00K-216.00K
interest expense00000
depreciation and amortization193.00K196.00K3.091M3.168K3.122K
ebitda-3.411M-3.71M825.00K-3.168M-3.122M
ebitda ratio00000
operating income-3.604M-3.906M-3.091M-3.168M-3.122M
operating income ratio00000
total other income expenses net193.00K196.00K825.00K206.00K706.00K
income before tax-3.411M-3.71M-2.266M-2.962M-2.416M
income before tax ratio00000
income tax expense00-3.091M-3.168K-3.122K
net income-3.411M-3.71M-2.266M-2.962M-2.416M
net income ratio00000
eps-1.53-2.17-1.64-2.15-1.77
eps diluted-1.53-2.17-1.64-2.15-1.77
weighted average shs out2.234M1.712M1.381M1.381M1.367M
weighted average shs out dil2.234M1.712M1.381M1.381M1.367M
Graph

GTBP Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents6.418M9.249M1.95M1.079M2.648M
short term investments007.857M12.893M13.366M
cash and short term investments6.418M9.249M9.807M13.972M16.014M
net receivables00000
inventory00000
other current assets341.00K18.00K78.00K84.00K38.00K
total current assets6.759M9.267M9.885M14.056M16.052M
property plant equipment net0027.00K53.00K87.00K
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00000
other non current assets00009.00K
total non current assets0027.00K53.00K96.00K
other assets00000
total assets6.759M9.267M9.912M14.109M16.148M
account payables2.612M1.717M3.213M4.328M3.97M
short term debt0030.00K58.00K92.00K
tax payables00000
deferred revenue00000
other current liabilities2.05M2.042M1.357M2.247M1.028M
total current liabilities4.662M3.759M4.60M6.633M5.09M
long term debt00000
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00001.053M
total non current liabilities00001.053M
other liabilities00000
capital lease obligations0030.00K58.00K92.00K
total liabilities4.662M3.759M4.60M6.633M6.143M
preferred stock1.00K1.00K1.00K1.00K1.00K
common stock2.00K2.00K1.00K1.00K42.00K
retained earnings-691.452M-688.041M-684.331M-682.065M-679.103M
accumulated other comprehensive income loss00-1.00K-1.00K-1.00K
other total stockholders equity693.546M693.546M689.641M689.54M689.066M
total stockholders equity2.097M5.508M5.312M7.476M10.005M
total equity2.097M5.508M5.312M7.476M10.005M
total liabilities and stockholders equity6.759M9.267M9.912M14.109M16.148M
minority interest00000
total investments06.57M7.857M12.893M13.366M
total debt0030.00K58.00K92.00K
net debt-6.418M-9.249M-1.92M-1.021M-2.556M
Graph

GTBP Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00000
stock based compensation120.00K102.00K433.00K862.00K259.00K
change in working capital147.00K-1.369M376.00K395.00K1.043M
accounts receivables00000
inventory00000
accounts payables116.00K-1.347M525.00K379.00K1.081M
other working capital31.00K-22.00K-149.00K-379.00K-38.00K
other non cash items-89.00K818.999K106.00K-805.00K-1.245M
net cash provided by operating activities-3.536M-4.163M-2.047M-1.964M-1.935M
investments in property plant and equipment00000
acquisitions net00000
purchases of investments05.034M478.00K1.845M2.657M
sales maturities of investments7.859M5.034M000
other investing activites7.859M5.034M000
net cash used for investing activites7.859M5.034M478.00K1.845M2.657M
debt repayment000-82.00K0
common stock issued2.976M00400.00K0
common stock repurchased00000
dividends paid00000
other financing activites2.976M0082.00K0
net cash used provided by financing activities2.976M00400.00K0
effect of forex changes on cash000498.00K0
net change in cash729.00K871.00K-1.569M-119.00K722.00K
cash at end of period2.679M1.95M1.079M2.648M2.767M
cash at beginning of period1.95M1.079M2.648M2.767M2.045M
operating cashflow-3.536M-4.163M-2.047M-1.964M-1.935M
capital expenditure00000
free cash flow-3.536M-4.163M-2.047M-1.964M-1.935M
Graph

Frequently Asked Questions

How did GT Biopharma, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, GTBP generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did GT Biopharma, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. GT Biopharma, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.

Have GTBP's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. GTBP incurred $3.60M worth of Operating Expenses, while it generated -$3.60M worth of Operating Income.

How much Net Income has GTBP posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from GT Biopharma, Inc., the company generated -$3.41M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did GT Biopharma, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to GT Biopharma, Inc. as of the end of the last quarter was $6.42M.

What are GTBP's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, GTBP had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did GT Biopharma, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of GTBP were $6.76M, while the Total Assets stand at $6.76M.

As of the last quarter, how much Total Debt did GT Biopharma, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of GTBP's debt was $0.00 at the end of the last quarter.

What were GTBP's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, GTBP reported total liabilities of $4.66M.

How much did GTBP's Working Capital change over the last quarter?

Working Capital Change for GTBP was $147.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

GTBP generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. GTBP generated -$3.54M of Cash from Operating Activities during its recently reported quarter.

What was GTBP's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. GTBP reported a $729.00K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph